Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Beale, A. S.
Right arrow Articles by Slocombe, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beale, A. S.
Right arrow Articles by Slocombe, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1991) 27, 627-638
© 1991 The British Society for Antimicrobial Chemotherapy

research-article

Comparative activities of amoxycillin, amoxycillin/clavulanic acid and tetracycline against Chlamydia trachomatis in cell culture and in an experimental mouse pneumonitis

Angela S. Beale, Eleanor Faulds, Sarah E. Hurn, Jennifer Tyler and Brian Slocombe

SmithKline Beecham Pharmaceuticals, Brockham Park Betchworth, Surrey, RH3 7AJ, UK

Received 15 October 1990; accepted 9 January 1991

The activity of amoxycillin, amoxycillin/clavulanic acid and two tetracycline antibiotics was investigated against three strains of Chlamydia trachomatis in vitro. McCoy cells were infected and single doses of antibiotic administered 24 h after infection. The percentage of infected cells was calculated at intervals up to 72 h after infection. Amoxycillin and clavulanic acid, alone and in combination, reduced the incidence of inclusion formation of all three strains. Particularly good activity was observed against the laboratory-adapted strain C. trachomatis Sa2F; and a clinical isolate C. trachomatis LB1, where a progressive reduction in numbers of inclusions was observed with time. Minocycline and oxytetracycline were the most active agents tested. In an experimental animal model, mice were inoculated intranasally with C. trachomatis MoPn (ATCC VR123) which caused a fatal pneumonia within 16 days, and treated orally for four days commencing at 24 h after infection. At doses producing clinically achievable serum concentrations, amoxycillin (10 mg/kg), amoxycillin/clavulanic acid (10 ² 5 mg/kg) and minocycline (5 mg/kg) all protected the mice over a 21-day period. The majority of the animals treated with clavulanic acid alone (20 mg/kg) survived the infection. Treatment with oxytetracycline was less effective, a dose of 160 mg/kg being required to protect 70% of the mice. The results indicate that amoxycillin and amoxycillin/clavulanic acid were more effective against C. trachomatis MoPn in vivo than might be predicted from in-vitro data, suggesting that amoxycillin/clavulanic acid may have potential for the treatment of polymicro-bial infections involving C. trachomatis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
A. Beceiro, R. Lopez-Rojas, J. Dominguez-Herrera, F. Docobo-Perez, G. Bou, J. Pachon, and the Spanish Network for Research in Infectious Dis
In Vitro Activity and In Vivo Efficacy of Clavulanic Acid against Acinetobacter baumannii
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4298 - 4304.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. Finlay, L. Miller, and J. A. Poupard
A review of the antimicrobial activity of clavulanate
J. Antimicrob. Chemother., July 1, 2003; 52(1): 18 - 23.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
X. X. Bin, K. Wolf, T. Schaffner, and R. Malinverni
Effect of Azithromycin plus Rifampin versus Amoxicillin Alone on Eradication and Inflammation in the Chronic Course of Chlamydia pneumoniae Pneumonitis in Mice
Antimicrob. Agents Chemother., June 1, 2000; 44(6): 1761 - 1764.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.